Zarate, Carlos A. (103 results)

Condition: very_good. Gently read. May have name of previous ownership, or ex-library edition. Binding tight; spine straight and smooth, with no creasing; covers clean and crisp. Minimal signs of handling or shelving. 100% GUARANTEE! Shipped with delivery confirmation, if you're not satisfied with purchase please return item! Ships USPS Media Mail.…

hardcover. Condition: Fine. Hardcover. Book never cracked open. Binding tight and new. Clean text - NO writing, NO highlighting to text. Touch of wear to front panel. Very good+ Oversized. Clean text -- NO writing, NO highlighting to text.ÂPLEASE NOTE: Domestic US media (standard) US orders ONLY. NO international orders.…

Condition: New. Dust Jacket Condition: New. Enviamos a todo el mundo. 100% garant'a. Libro nuevo.

Hardcover. Condition: Fine. No Jacket. 1st Edition. 2016.Hardcover.Fine condition.155 pages.Ships from Japan.Usually ships in 1-2 working days.

Condition: New.

PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.

Paperback. Condition: New. Brand new book, sourced directly from publisher. Dispatch time is 24-48 hours from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely.

hardcover. Condition: new.

Condition: As New. Unread book in perfect condition.

Taschenbuch. Condition: Neu. Action, Linkage and Legality of Government Procurement | For Local Development and Social Economy Actors | Carlos Daniel Zarate (u. a.) | Taschenbuch | Englisch | 2023 | Our Knowledge Publishing | EAN 9786206908838 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu.…

Condition: New.

Paperback. Condition: new. Paperback. Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Paperback. Condition: New. Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics.…

Condition: New. In English.

Condition: New. 2020. Paperback. . . . . .

Condition: As New. Unread book in perfect condition.

Paperback. Condition: New. Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics.…

Paperback. Condition: Brand New. 150 pages. 9.25x7.50x1.42 inches. In Stock.

Paperback / softback. Condition: New. New copy - Usually dispatched within 3 working days.

Condition: NEW.

Condition: New.

Hardcover. Condition: Brand New. 155 pages. 9.25x6.25x0.75 inches. In Stock.

Condition: New. 2020. Paperback. . . . . . Books ship from the US and Ireland.

Hardcover. Condition: new. Hardcover. This book brings together an international group of clinicians and researchers from a broad swath of inter-related disciplines to offer the most up-to-date information about clinical and preclinical research into ketamine and second-generation ketamine-like fast-acting antidepressants.Currently available antidepressant medications act through monoaminergic systems, are ineffective for many individuals suffering from depression, and are associated with a delayed onset of peak efficacy of several months. The unexpected emergence of ketamine, an anesthetic N-methyl-D-aspartate (NMDA) receptor antagonist, as a rapid-acting antidepressant has reinvigorated CNS drug discovery research and catalyzed investigation in patient populations historically ignored in antidepressant drug development programs, particularly treatment-resistant patients and those with suicidality. Recent industry and academic research efforts have coalesced to explore NMDA receptor and glutamatergic moleculartargets that lack ketamines psychotomimetic side effects and abuse liability but retain its rapid onset of efficacy. However, many fundamental questions remain regarding the neurobiological mechanisms underlying ketamines rapid antidepressant effects and the puzzling persistence of benefits observed in some patients following a single dose. This book examines how insights from these studies are forging new conceptual models of the neurobiology of stress-related affective, anxiety, and addictive disorders and the nature of treatment resistance. It also discusses how ketamines rapid antidepressant effects provide a scientific platform to facilitate innovation in clinical trial designs pertaining to patient selection, choice of control group, outcome measures, and dose-optimization. This book brings together data and insights from this rapidly expanding and extraordinarily promising field of study. Readers will be able to extract integrated themes and useful insights from the material contained in these diverse chapters and appreciate the paradigm-shifting contributions of ketamine to modern psychiatry and clinical neuroscience research. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book brings together an international group of clinicians and researchers from a broad swath of inter-related disciplines to offer the most up-to-date information about clinical and preclinical research into ketamine and second-generation 'ketamine-like' fast-acting antidepressants.Currently available antidepressant medications act through monoaminergic systems, are ineffective for many individuals suffering from depression, and are associated with a delayed onset of peak efficacy of several months. The unexpected emergence of ketamine, an anesthetic N-methyl-D-aspartate (NMDA) receptor antagonist, as a rapid-acting antidepressant has reinvigorated CNS drug discovery research and catalyzed investigation in patient populations historically ignored in antidepressant drug development programs, particularly treatment-resistant patients and those with suicidality. Recent industry and academic research efforts have coalesced to explore NMDA receptor and glutamatergic moleculartargets that lack ketamine's psychotomimetic side effects and abuse liability but retain its rapid onset of efficacy. However, many fundamental questions remain regarding the neurobiological mechanisms underlying ketamine's rapid antidepressant effects and the puzzling persistence of benefits observed in some patients following a single dose. This book examines how insights from these studies are forging new conceptual models of the neurobiology of stress-related affective, anxiety, and addictive disorders and the nature of treatment resistance. It also discusses how ketamine's rapid antidepressant effects provide a scientific platform to facilitate innovation in clinical trial designs pertaining to patient selection, choice of control group, outcome measures, and dose-optimization. This book brings together data and insights from this rapidly expanding and extraordinarily promising field of study. Readers will be able to extract integrated themes and useful insights from the material contained in these diverse chapters and appreciate the paradigm-shifting contributions of ketamine to modern psychiatry and clinical neuroscience research.…

Gebunden. Condition: New.

Condition: New. pp. XIX, 155 6 illus., 3 illus. in color. 1 Edition NO-PA16APR2015-KAP.

Condition: New. Provides efficacy research on ketamine as a treatment for depression Identifies best practices for clinical use, both long-term and acute Discusses the molecular mechanisms and neurobiology of actionRedaktion: Gu.

Taschenbuch. Condition: Neu. Ketamine for Treatment-Resistant Depression | Neurobiology and Applications | Gustavo H. Vazquez (u. a.) | Taschenbuch | Einband - flex.(Paperback) | Englisch | 2020 | Elsevier Science Publishing Co Inc | EAN 9780128210338 | Verantwortliche Person für die EU: Elsevier B.V., Radarweg 29, 1043 NX AMSTERDAM, NIEDERLANDE, productsafety[at]elsevier[dot]com | Anbieter: preigu.…